BBY vs RYTM · P/E 14, rev $41.53B vs rev $130.1M
Best Buy Co. Inc (BBY) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported BBY revenue for 2025-02-01 was $41.53B. Net income was $927.0M. Revenue was down 4.4% from 2024-02-03 to 2025-02-01. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the BBY and RYTM stock pages for the full models.
Not investment advice.